All eyes on $HIMS next week! 👀 On July 23-24, the FDA’s Pharmacy Compounding Advisory Committee will review 7 peptides for 503A eligibility. I expect favorable recommendations. That could be a major positive for $HIMS. Are you well positioned?
View on X ↗